Technology · Biotechnology R&D expenditure
Japan is a global leader in biotechnology investment: in 2026, R&D spending in this field reached 25 B $. This is the 3rd place among 197 countries. Massive funds are channeled into genetic engineering, drug discovery, and medical devices. Key research clusters are located in Tokyo, Osaka, and Tsukuba, where universities and pharmaceutical giants like Takeda and Astellas conduct cutting-edge work.
Data for 2026 · unit: $
Position
#3 / 197
Japan world ranking
Country position on the scale from last to first place for this indicator.
JP
#3
#197#1
Trend
Change over time
Change in indicator over the available period.
5 B
1990
12 B
2000
18 B
2010
22 B
2020
25 B
2025
25 B
2026
Values — $
Comparison
Top countries by Biotechnology R&D expenditure
Where Japan stands in the world ranking.
1
CNChina
30 B
1
USUSA
30 B
3
JPJapan
25 B
4
MXMexico
1 B
4
BRBrazil
1 B
6
CACanada
800 M
6
DEGermany
800 M
8
ESSpain
650 M
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Biotechnology R&D expenditure in Japan — how much?
Based on 2026 data — 25 B $. This is rank #3 out of 197 countries.
What is Japan's rank by Biotechnology R&D expenditure?
Japan ranks #3 out of 197 countries in the world ranking by «Biotechnology R&D expenditure».
How has Biotechnology R&D expenditure changed in Japan?
Over the available period the indicator changed from 5 B to 25 B $.